timbetasin intravenous (RGN-352) / Lee's Pharm, RegeneRx  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
timbetasin intravenous (RGN-352) / RegeneRx
NCT00743769: A Phase 1 Safety Study of the Intravenous Administration of Thymosin Beta in Healthy Volunteers

Withdrawn
1
0
US
thymosin beta 4, Placebo
RegeneRx Biopharmaceuticals, Inc.
Myocardial Infarction, Myocardial Ischemia
01/17
01/17

Download Options